These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3608284)

  • 21. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy.
    Lussier-Cacan S; Xhignesse M; Desmarais JL; Davignon J; Kafrissen ME; Chapdelaine A
    Metabolism; 1991 Aug; 40(8):849-54. PubMed ID: 1907348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception.
    Balogh A; Ditrói F; Lampé LG
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():95-101. PubMed ID: 6242699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysfunctional uterine bleeding in ovulatory women.
    Strickler RC
    Postgrad Med; 1985 Jan; 77(1):235-7, 240-3, 246. PubMed ID: 3880890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The efficiency of oral contraception containing drospirenone in treating symptoms of premenstrual syndrome or premenstrual dysphoric disorder in gyneacology practice].
    Svojanovská K
    Ceska Gynekol; 2010 Oct; 75(5):474-80. PubMed ID: 21374928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of the etiology and treatment of premenstrual syndrome.
    True BL; Goodner SM; Burns EA
    Drug Intell Clin Pharm; 1985 Oct; 19(10):714-22. PubMed ID: 3902431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The treatment of late luteal phase dysphoric disorder.
    Steinberg S
    Life Sci; 1991; 49(11):767-802. PubMed ID: 1875788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
    Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing the premenstrual syndrome.
    Smith MA; Youngkin EQ
    Clin Pharm; 1986 Oct; 5(10):788-97. PubMed ID: 3536266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal and menstrual changes after laparoscopic sterilization by Falope-rings or Filshie-clips.
    Thranov I; Hertz JB; Kjer JJ; Andresen A; Micic S; Nielsen J; Hancke S
    Fertil Steril; 1992 Apr; 57(4):751-5. PubMed ID: 1532561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Premenstrual syndrome. Evidence-based treatment in family practice.
    Douglas S
    Can Fam Physician; 2002 Nov; 48():1789-97. PubMed ID: 12489244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Problems in the treatment of premenstrual syndrome.
    Robinson GE; Garfinkel PE
    Can J Psychiatry; 1990 Apr; 35(3):199-206. PubMed ID: 2187582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bromocriptine and premenstrual tension: a clinical and hormonal study.
    Andersch B; Hahn L
    Pharmatherapeutica; 1982; 3(2):107-13. PubMed ID: 7201645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal profile in IUD users.
    Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
    Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indications for drug therapy in premenstrual syndrome patients.
    Chihal HJ
    J Reprod Med; 1987 Jun; 32(6):449-52. PubMed ID: 2956417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptoms of premenstrual syndrome and their association with migraine headache.
    Martin VT; Wernke S; Mandell K; Ramadan N; Kao L; Bean J; Liu J; Zoma W; Rebar R
    Headache; 2006 Jan; 46(1):125-37. PubMed ID: 16412160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic effects of low-dose fluconazole in healthy female users and non-users of oral contraceptives.
    Devenport MH; Crook D; Wynn V; Lees LJ
    Br J Clin Pharmacol; 1989 Jun; 27(6):851-9. PubMed ID: 2547410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An overview of premenstrual syndrome].
    Zaafrane F; Faleh R; Melki W; Sakouhi M; Gaha L
    J Gynecol Obstet Biol Reprod (Paris); 2007 Nov; 36(7):642-52. PubMed ID: 17321695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study.
    Wang M; Hammarbäck S; Lindhe BA; Bäckström T
    Acta Obstet Gynecol Scand; 1995 Nov; 74(10):803-8. PubMed ID: 8533564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy.
    Blazar AS; Harlin J; Zaidi AA; Diczfalusy E
    Fertil Steril; 1980 May; 33(5):493-500. PubMed ID: 6768597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.